Skip to main content
SpringerLink
Log in

Vergleich einer Insulintherapie mit Insulin Glargin und Insulin Degludec/Liraglutid bei Patienten mit Typ-2-Diabetes

Comparison of insulin therapy with Insulin Glargin and Insulin Degludec/Liraglutid in patients with type 2 diabetes

  • Journal Club
  • Published:
Der Diabetologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Inzucchi SE, Bergenstal RM, Buse JB et al (2015) Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 38(1):140–149

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Endokrinologie und Diabetologie, Universitätsklinik Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Deutschland

    S. Kahl

Authors
  1. S. Kahl
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Kahl.

Ethics declarations

Interessenkonflikt

Dr. S. Kahl gibt an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kahl, S. Vergleich einer Insulintherapie mit Insulin Glargin und Insulin Degludec/Liraglutid bei Patienten mit Typ-2-Diabetes. Diabetologe 12, 201–202 (2016). https://doi.org/10.1007/s11428-016-0090-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11428-016-0090-9

Search

Navigation